Lumipulse® G pTau 181

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 181 (pTau 181) in human cerebrospinal fluid (CSF).

This CSF biomarker is intended to be used as an aid for diagnosis in patients with cognitive impairment who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline.

The CSF biomarker supports the probability of AD pathology only as an adjunct to other diagnostic evaluations.

      Lumipulse® G pTau 181 Immunoreaction Cartridges

      Product number 230350

      3 x 14 Tests
      Lumipulse® G pTau 181 Calibrators set

      Product number 230367

      1 x 3 concentrations
      CE marked (IVDR)
      Please contact your local Fujirebio representative for the availability of this product in your country.
      Lumipulse G pTau 181 Immunoreaction Cartridges (230350) and Lumipulse G pTau 181 Calibrators set (230367) Lumipulse G CLIA analyzer cartridge close up LUMIPULSE G1200 fully automated CLEIA analyzer - cartridge loading

      Click here to navigate

      • Details
      • Conditions of sale
      • Citations
      • Documentation
      • Insights
      • Related products
      • Webinars

      • Details

        See the LUMIPULSE G1200 working in this video:

         

      • Conditions of sale

        To read the end user conditions of sale for this product please visit our Resource center.

      • Citations

        The BIOZ badges associated with Fujirebio products include peer-reviewed citations derived from scientific studies using Fujirebio products. Please note that the peer-reviewed citations do not reflect the regulatory status of Fujirebio products. Users should refer to the specific product documentation and any (clinical) claims made therein in order to ensure compliant use. For each country or geographic region, users must verify the related regulatory status of the Fujirebio product.

      • Insights

        • Review past webinars

        Neurodegenerative diseases
        Replay available
        2026/03/03 - 10:00 AM EST / 16:00 CET

        Mapping Synaptic Loss: Where β‑synuclein Fits in the Biomarker Landscape

        Watch replay
        Neurodegenerative diseases
        Replay available
        2025/11/19 - 10:00 AM EST / 16:00 CET

        Unlocking the biology of dementia with Lewy bodies: Biomarker insights from DDC to synapses

        Watch replay
        Neurodegenerative diseases
        Replay available
        2021/11/18 - 18 November 2021

        Preparing for the future of plasma based Alzheimers disease diagnostics

        Watch replay

      Veuillez confirmer que vous êtes un professionnel de la santé

      Choose your country or region